Standout Papers

Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura 2019 2026 2021 2023 577
  1. Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura (2019)
    Marie Scully, Spero R. Cataland et al. New England Journal of Medicine

Immediate Impact

1 by Nobel laureates 2 from Science/Nature 54 standout
Sub-graph 1 of 23

Citing Papers

The present and future of bispecific antibodies for cancer therapy
2024 Standout
Systemic Lupus Erythematosus
2024 Standout
3 intermediate papers

Works of Debjit Biswas being referenced

Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura
2019 Standout

Author Peers

Author Last Decade Papers Cites
Debjit Biswas 54 398 214 181 12 742
S Korec 63 501 227 157 14 845
Mohamed R. Daha 45 387 91 250 18 743
Roelof Flierman 35 529 59 74 13 710
Norifumi Sawamukai 27 260 132 48 25 657
N. Gunnar Westberg 105 224 104 385 21 933
Amy M. Bertino 89 213 504 46 10 884
Glenn R. Ehresmann 67 251 61 45 13 726
Allen R. Hendricks 71 443 44 236 16 905
Stephen R. Holdsworth 139 449 68 323 9 802
P Martin-Dupont 34 450 364 60 9 869

All Works

Loading papers...

Rankless by CCL
2026